Fulgent Genetics (FLGT) Total Liabilities (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Total Liabilities data on file, last reported at $112.2 million in Q1 2026.

• Quarterly Total Liabilities rose 35.24% year-over-year to $112.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.2 million (up 35.24% YoY) and the FY2025 annual result came in at $106.8 million, up 17.63% from the prior year.
• Total Liabilities advanced to $112.2 million in Q1 2026 per FLGT's latest filing, from $106.8 million in the prior quarter.
• The five-year high for Total Liabilities was $152.6 million in Q1 2022, with the low at $83.0 million in Q1 2025.
• Average Total Liabilities over 5 years is $107.2 million, with a median of $103.2 million recorded in 2024.
• Year-over-year, Total Liabilities slumped 39.54% in 2023 and jumped 35.24% in 2026.
• Fulgent Genetics' Total Liabilities stood at $116.2 million in 2022, then fell by 12.17% to $102.0 million in 2023, then slipped by 11.01% to $90.8 million in 2024, then increased by 17.63% to $106.8 million in 2025, then climbed by 5.06% to $112.2 million in 2026.
• Business Quant data shows FLGT's Total Liabilities at $112.2 million in Q1 2026, $106.8 million in Q4 2025, and $93.8 million in Q3 2025.